Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.4, 2014-04, pp. : 421-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does aspirin increase the risk of age-related macular degeneration?

By Chong Elaine W Guymer Robyn H Robman Liubov D

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 691-693

Informa Healthcare

Access to resources Recommend Favorite

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey Mrejen Sarah Gallego-Pinazo Roberto

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V. Kaiser Peter K.

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew Kaiser Peter K

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

By Moshfeghi Andrew A Puliafito Carmen A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 671-682

Informa Healthcare

Access to resources Recommend Favorite